C000085163 Fees and Costs — Invesco Balanced-Risk Retirement 2030 Fund, Class AX
Data updated: 2021-03-15
The net expense ratio is 1.12% (1.70% before fee waivers). This share class carries a maximum front-end sales load of 5.50%. Portfolio turnover was 11%.
C000085163 Fees and Expenses
Annual operating expenses and sales charges of C000085163. Prospectus, as of April 30, 2020.
| Annual operating expenses | |
|---|---|
| Management fee | 0.00% |
| 12b-1 fee | 0.25% |
| Other expenses | 0.58% |
| Gross expense ratio | 1.70% |
| Fee waiver | −0.58% |
| Net expense ratio | 1.12% |
| Sales charges | |
|---|---|
| Max front load | 5.50% |
| Max deferred load | 0.00% |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | Yes |
| Fees waived or reduced during the year | Yes |
| Waived fees subject to recoupment | No |
C000085163 Costs Over Time
On $10,000 invested in C000085163, assuming 5% a year before costs, total costs come to $1,362 over 5 years, cutting the return by 2.34% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Sales charges | $550 | $550 | $550 |
| Fund expenses (net expense ratio 1.12%) | $111 | $346 | $600 |
| Lost growth on money paid in costs | $27 | $104 | $213 |
| Total costs | $689 | $1,000 | $1,362 |
| Value after costs | $9,811 | $10,576 | $11,400 |
| Impact on return, per year | 6.89% | 3.12% | 2.34% |
C000085163 Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending December 31, 2020.
- Explicit cost rate (commissions ÷ average net assets): —
- Total broker commissions: —
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 11%
- Securities lending: none during the year
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.